Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Our Plans

Compare everything

See all plans, pricing and what each product includes side by side.

Plans & Subscriptions

Explore

Analyst Notes

Stocks – Q : Quality | V : Valuation | PT : Price Trend
Funds – P : Performance | Q : Quality

Top Pharma Companies in India by Market Cap

BSE Sensex 76923.00
87.22 (0.11%)

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
121	Novartis India Ltd.	Q V+ PT	4,023 Small Cap	1,614.10 (-0.92%)	41.14	4.73	-4.06	54.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
122	Artemis Medicare Services Ltd.	Q V PT	4,408 Small Cap	278.40 (-0.02%)	42.61	5.07	21.41	79.02	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
123	3B Blackbio Dx Ltd.	Q V PT	1,112 Small Cap	1,290 (-0.39%)	22.54	4.07	46.29	132.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
124	Yatharth Hospital & Trauma Care Services Ltd.	Q V PT	8,132 Small Cap	841.90 (-0.25%)	85.24	5.02	27.90	137.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
125	Max Healthcare Institute Ltd.	Q V PT	1,08,476 Mid Cap	1,112.35 (-0.20%)	75.2	10.23	27.27	155.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Company Name	CMP	Price Change(%)
Onesource Specialty	1,744.75	3.26%
Dr. Agarwals Health	487.60	2.53%
Metropolis Health.	590.30	2.17%
Laurus Labs	1,745.85	1.84%
Cipla	1,434.80	1.77%

Company Name	CMP	Price Change(%)
Acutaas Chemicals	3,121.05	-7.35%
Senores Pharmaceutic	1,317.55	-6.66%
Suven Life Sciences	297.85	-4.44%
Wanbury	318.55	-3.82%
Panacea Biotec	418.10	-3.51%

News about Top Pharma Companies in India

Jul, 2026

Novartis India - Quaterly Results

The June 2026 quarter revenue stood at Rs. 1038.10 millions, up 18.57% as compared to Rs. 875.50 millions during the corresponding quarter last year.A humble growth in net profit of 16.62% reported in the quarter ended June 2026 to Rs. 322.10 millions from Rs. 276.20 millions.The company reported a good operating profit of 436.50 millions compared to 378.50 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202606	202506	% Var	202606	202506	% Var	202603	202503	% Var
Sales	1038.10	875.50	18.57	1038.10	875.50	18.57	3543.30	3562.70	-0.54
Other Income	87.40	106.10	-17.62	87.40	106.10	-17.62	387.70	419.60	-7.60
PBIDT	436.50	378.50	15.32	436.50	378.50	15.32	1328.70	1333.80	-0.38
Interest	0.60	1.00	-40.00	0.60	1.00	-40.00	12.60	7.70	63.64
PBDT	435.90	377.50	15.47	435.90	377.50	15.47	1316.10	1326.10	-0.75
Depreciation	4.20	5.30	-20.75	4.20	5.30	-20.75	19.50	21.90	-10.96
PBT	431.70	372.20	15.99	431.70	372.20	15.99	1296.60	1304.20	-0.58
TAX	109.60	96.00	14.17	109.60	96.00	14.17	364.80	295.20	23.58
Deferred Tax	-5.00	0.00	0.00	-5.00	0.00	0.00	15.30	-4.40	-447.73
PAT	322.10	276.20	16.62	322.10	276.20	16.62	931.80	1009.00	-7.65
Equity	123.40	123.40	0.00	123.40	123.40	0.00	123.40	123.40	0.00
PBIDTM(%)	42.05	43.23	-2.74	42.05	43.23	-2.74	37.50	37.44	0.16

Jul, 2026

Artemis Medicare Service informs about newspaper advertisement

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Artemis Medicare Service has informed that it enclosed the copy of the advertisement published in the newspapers, The Financial Express (English National Daily Newspaper- all editions) and The Jansatta (Hindi National Daily Newspaper- Delhi edition) on July 15, 2026, regarding the public notice for the opening of a Special Window for Transfer and Dematerialisation of Physical Securities.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Max Healthcare Institute informs about disclosure

Max Healthcare Institute has informed that this is in continuation to the earlier intimation dated May 19, 2026, regarding ongoing litigation against Kalinga Hospital (KHL), a subsidiary of the Company, other shareholder of KHL from whom the Company acquired the majority equity stake, including the Company under section 241 and 242 of the Companies Act, 2013. Subsequently, an interlocutory petition has been filed before the Hon’ble National Company Law Tribunal, Cuttack Bench (NCLT) by legal representatives of BRS Capital Two Pte. Limited requesting stay on the Postal Ballot Notice dated May 29, 2026 issued by KHL in relation to increasing borrowing limits and creating charge on assets of the Company. The said petitions were listed before the NCLT on July 7, 2026 at 11.30 am (IST). Details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure. This disclosure will also be hosted on Company's website, www.maxhealthcare.in.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Artemis Medicare Services informs about trading window closure

Artemis Medicare Services has informed that the trading window for trading in securities of the Company will remain closed for all Concerned Persons with effect from July 1, 2026 till 48 hours after the declaration of financial results of the Company for the quarter ending June 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Max Healthcare Institute informs about AGM & record date

Max Healthcare Institute has informed about the following with respect to Annual General Meeting, Record Date and Communication sent to members for deduction of tax at source on final dividend: 1) Annual General Meeting: The Twenty-Fifth Annual General Meeting (‘AGM’) of members of the Company is scheduled to be held on Thursday, July 30, 2026 through video conference / other audio-visual means, in accordance with the applicable circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India (‘SEBI’). 2) Record Date: Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Friday, July 3, 2026, as the ‘Record Date’ for determining the members entitled to receive the final dividend for the financial year 2025-26, if approved by members at the ensuing 25th AGM. 3) Communication to member for deduction of tax at source on final dividend: The Company has today, June 19, 2026, sent a detailed communication to all members of the Company, whose e-mail addresses are registered with the Company/ depositories, indicating the process and documentation required for claiming exemption from deduction of tax at source on final dividend for the financial year 2025-26, which is subject to the approval of members at the ensuing 25th AGM. A copy of e-mail communication sent to members is enclosed as Annexure. This disclosure will also be hosted on Company's website: www.maxhealthcare.in.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Yatharth Hospital completes acquisition of hospital asset in Gurugram

The transaction formalities pertaining to the Hospital asset acquisition have been duly completed on June 12, 2026

Rank	Company	Market Capitalization 2026 (INR crores)
1	Nectar Lifesciences Ltd.	202 Crore
2	Health X Platform Ltd.	985 Crore
3	Indoco Remedies Ltd.	2,287 Crore
4	Unichem Laboratories Ltd.	3,826 Crore
5	Solara Active Pharma Sciences Ltd.	2,439 Crore
6	Suraksha Diagnostic Ltd.	1,300 Crore
7	Jubilant Pharmova Ltd.	15,582 Crore
8	Dishman Carbogen Amcis Ltd.	2,922 Crore
9	Biocon Ltd.	71,063 Crore
10	Shilpa Medicare Ltd.	12,144 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,893	59,102	38.08	12.45	26.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,922	1,90,832	88.21	22.69	45.79	29.04
Lupin Ltd. (M)	Somewhat Good	2,405	1,10,189	20.66	4.92	11.95	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,358	42,278	40.04	9.35	27.05	25.35
Alkem Laboratories Ltd. (M)	Very Good	5,631	67,124	30.72	4.80	22.28	17.86

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,746	92,623	105
Sai Life Sciences Ltd. (S)	Very Good	1,291	27,347	53.73
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,922	1,90,832	39.27
Aurobindo Pharma Ltd. (M)	Very Good	1,553	89,115	38.01
Lupin Ltd. (M)	Somewhat Good	2,405	1,10,189	23.52
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Very Good	1,291	27,347	80.08	10.90	42.11	17.75
Ajanta Pharma Ltd. (M)	Very Good	3,358	42,278	40.04	9.35	27.05	13.54
Mankind Pharma Ltd. (M)	Very Good	2,587	1,05,357	51.71	6.44	32.38	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,109	1,10,523	21.93	4.25	13.45	13.52
Lupin Ltd. (M)	Somewhat Good	2,405	1,10,189	20.66	4.92	11.95	13.02

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Lupin Ltd. (M)	Somewhat Good	2,405	1,10,189	20.66	4.92	11.95	32.37
Abbott India Ltd. (M)	Very Good	27,893	59,102	38.08	12.45	26.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,146	96,063	29.81	2.52	15.31	15.75
Zydus Lifesciences Ltd. (M)	Very Good	1,109	1,10,523	21.93	4.25	13.45	14.72
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,984	4,73,509	41.25	5.67	23.65	14.41

About MoneyWorks4Me

*Color code for outperformance consistency

*Number is average 3 year rolling returns

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Novartis India - Quaterly Results

Artemis Medicare Service informs about newspaper advertisement

Max Healthcare Institute informs about disclosure

Artemis Medicare Services informs about trading window closure

Max Healthcare Institute informs about AGM & record date

Yatharth Hospital completes acquisition of hospital asset in Gurugram

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Novartis India - Quaterly Results

Artemis Medicare Service informs about newspaper advertisement

Max Healthcare Institute informs about disclosure

Artemis Medicare Services informs about trading window closure

Max Healthcare Institute informs about AGM & record date

Yatharth Hospital completes acquisition of hospital asset in Gurugram

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.